Payton Nyquvest On Numinus Q4 and Reduced Cash Burn

You’ve been asking where Payton has been, so we listened! On today’s exciting episode of The Dales Report Exclusive, we have the CEO of Numinus (NUMI), Payton Nyquvest back to the show. In today’s podcast, he’s going to talk to us about trends in the alternative therapy field, and some of Numinus’ recent updates including their reduced cash burn rate.

At the end of November, Numinus posted their Q4 and Full Year Fiscal 2023 results. The report had a lot of positive information in it, including demonstrable YOY growth for the company, plus a reduced cash burn rate for October. You can read all about it here. Payton says that the feedback on Numinus’ results has been tremendous.

Payton has indicated before that he wanted to get Numinus to a $1 million dollar burn rate. It was important, and he explains from an operational perspective where the company is going from here. Host Shadd Dales shares stable growth in clinical visitation levels for depressive disorder. They discuss positive trends in alternative treatments, while expressing optimism for 2024 as an election year with potential DEA rescheduling.

We explore the pathway of alternative therapy and the steps involved in its commercialization. Gain insights into the current state of the industry from Payton, who highlights renewed enthusiasm and investment interest, especially in the US. They emphasize the importance of education and commercialization pathways for alternative therapy, and you’ll find out why.

Learn about MAPS’ progress with compound-assisted therapy, including their FDA submission that is expected by the end of this year. The Breakthrough Therapy status will set a defined pathway for FDA review and DEA rescheduling. Payton expects a series-A financing announcement to address skepticism about the compound’s development.

Dovetailing with the importance of education, we discuss the industry growth of alternative therapy and the Numinus certification program. Despite challenges, positive feedback from practitioners reinforces their commitment to this evolving field.

Don’t miss out on this interview with Numinus Wellness’  Payton Nyquvest.


In accordance with an executed agreement between The Dales Report and Numiness Wellness Inc., The Dales Report is engaged with the aforementioned on a 12-month contract for $10,000 CDN per month, with the purpose of publicly disseminating information pertaining to Numinus Wellness via The Dales Report’s media assets, encompassing its website, diverse social media platforms, and YouTube channel. Compensation for The Dales Report services involves the receipt of a predefined monetary consideration, which may, on certain occasions, encompass ordinary shares in instances where monetary compensation was not obtained. In such instances where share compensation was received, The Dales Report hereby asserts the right to engage in the acquisition or disposition of such shares subsequent to the conclusion of the aforementioned contractual period, in compliance with provincial, state, and federal securities regulations. Please refer to the “Disclosures” section below, which is to be interpreted in conjunction with this disclaimer.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More